CIK 0001625297
- Large accelerated filer
Supernus, Inc.
Sign in to watch- Ticker
- SUPN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 412520873
- Phone
- +1 804-379-1090
- Business address
- 9715 KEY WEST AVENUE, ROCKVILLE, MD, 20850
- Former names
- Indivior Pharmaceuticals, Inc., INDIVIOR PLC
- 4 Other acquisition SVP, Chief Tech. Ops. Officer acquired 30,099 shares (other)
- 4 Derivatives Options or other derivatives
- 4 Other acquisition SVP, Chief Financial Officer acquired 14,059 shares (other)
- 4 Other acquisition Director acquired 41,652 shares (other)
- 4 Other acquisition SVP of IP, CSO acquired 28,702 shares (other)
- 4 Derivatives Options or other derivatives
- 4 Other acquisition Director acquired 42,009 shares (other)
- 4 Other acquisition Chief Executive Officer acquired 3,413,555 shares (other)
- 4 Other acquisition SVP, Chief Medical Officer acquired 21,529 shares (other)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Chief Accounting Officer bought 1,500 shares at $35.69 ($53,535)
- 4 Open-market buy Chief Accounting Officer bought 1,500 shares at $36.28 ($54,420)
Page 1 of 4 · 70 filings